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Background: Double Stranded Breaks (DSBs) are the most serious form of DNA damage and are repaired via
homologous recombination repair (HRR) or non-homologous end joining (NHEJ). NHEJ predominates in mammalian
cells at most stages of the cell cycle, and it is viewed as ‘error-prone’, although this notion has not been sufficiently
challenged due to shortcomings of many current systems. Multi-copy episomes provide a large pool of genetic
material where repair can be studied, as repaired plasmids can be back-cloned into bacteria and characterized for
sequence alterations. Here, we used EBV-based episomes carrying 3 resistance marker genes in repair studies where
a single DSB is generated with virally-encoded HO endonuclease cleaving rapidly at high efficiency for a brief time
post-infection. We employed PCR and Southern blot to follow the kinetics of repair and formation of processing
intermediates, and replica plating to screen for plasmids with altered joints resulting in loss of chloramphenicol
resistance. Further, we employed this system to study the role of Metnase. Metnase is only found in humans and
primates and is a key component of the NHEJ pathway, but its function is not fully characterized in intact cells.
Results: We found that repair of episomes by end-joining was highly accurate in 293 T cells that lack Metnase.
Less than 10% of the rescued plasmids showed deletions. Instead, HEK293 cells (that do express Metnase) or 293
T transfected with Metnase revealed a large number of rescued plasmids with altered repaired joint, typically in the
form of large deletions. Moreover, quantitative PCR and Southern blotting revealed less accurately repaired plasmids
in Metnase expressing cells.
Conclusions: Our careful re-examination of fidelity of NHEJ repair in mammalian cells carrying a 3′ cohesive
overhang at the ends revealed that the repair is efficient and highly accurate, and predominant over HRR. However,
the background of the cells is important in establishing accuracy; with human cells perhaps surprisingly much more
prone to generate deletions at the repaired junctions, if/when Metnase is abundantly expressed.
Keywords: Accuracy of DSB repair in mammalian cells, Episomal model of NHEJ, End- processing and re-ligation,
Metnase nuclease, Joint accuracyBackground
Double Stranded Breaks (DSBs), a serious type of
chromosome damage are usually caused by exogenous
agents such as ionizing radiation (IR), topoisomerase
poisons, radiomimetic drugs like bleomycin and doxo-
rubicin, or endogenous damages which arise as a result
of cellular metabolism (free radicals and DNA replica-
tion errors or collapse of stalled forks). Programmed
DSBs are also generated during processes such as V(D)J* Correspondence: adeben@lsuhsc.edu
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unless otherwise stated.recombination of immunoglobulin genes and during al-
lelic exchanges at meiosis or zygotic fusion. If misre-
paired, DSBs can result in chromosomal translocations,
oncogenesis, and genomic instability [1-3]. DSB repair
can be broadly divided into two major pathways: ho-
mologous recombination (HR) and non-homologous end
joining (NHEJ) [4]. HR requires the presence of an intact
homologous template, often a sister chromatid, which al-
lows accurate repair of DSBs via a replicative interme-
diate and is the preferred mode of repair in S and G2
phase of cell-cycle [5]. In contrast, NHEJ operates with-
out the need for a template DNA; sometimes joining the
ends with minimal processing, hence considered poten-
tially erroneous/mutagenic. NHEJ is the predominantd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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shown to operate all throughout the cell cycle [6].
Currently used DSB repair assays have several short-
comings. Researchers employ several methods such as
Ionizing radiation (IR), radiomimetic drugs, laser, and
site-specific endonucleases for induction of DNA dam-
age [7]. Of note, γ-irradiation and drug induced damage
foci are randomly dispersed and non-homogenous in na-
ture. Lasers create localized but exceedingly strong DNA
damage. In addition, different wavelengths of the laser
largely determine the damaged end structures subse-
quently resulting in widely different kinetics of repair
with differential protein requirement (for a review see
[7,8]). DSBs introduced with a nuclease are adequate for
studies of the molecular/cellular mechanisms, but esti-
mates of repair accuracy are problematic since these en-
zymes turn over slowly and thus selecting for erroneous
processing of the ends that eliminate the target se-
quence. This is well-known for the Endonuclease I-SceI
induced DSBs [9], a model that also suffers from the
need of pre-integration of the target sequence, and often
low cutting efficiency (either due to low transfection of
the cell population or because of the chromosomal loca-
tion of its target sequence). The Endonuclease I-Ppol
also suffers from low cleavage efficiency because of its
unique target location in the highly condensed and re-
petitive ribosomal DNA gene clusters. Furthermore,
study of repair at defined genomic DSBs is problematic
due to the difficulty in re-obtaining ‘clean clonal’ isolates
for analysis in sufficient representation. Likewise, use of
yeast as a model system to parlay mammalian NHEJ is
not entirely acceptable. Yeast like Saccharomyces cerevi-
siae or Saccharomyces pombe lack many well established
components of mammalian NHEJ, like DNA-PKcs and
Artemis. To date, orthologs for newly discovered NHEJ
components of human APLF, PNK, Metnase, and APTX
have not been identified in yeast [10]. Furthermore, HR
is the preferred repair pathway in yeast, whereas NHEJ
is the predominant pathway in mammalian cells [11].
In yeast, IR-induced and endonuclease-induced DSBs
are differentially processed in a cell cycle-dependent
manner [12].
Hence, we set out to develop one model system to effi-
ciently represent repair activities in mammalian cells in
a physiological setting, with episomes. Repair of multi-
copy plasmids provides a large pool of mostly uniform
genetic material where the repair process can be studied
[13-15]. We utilized the yeast HO endonuclease (a key
component of the mechanism for mating-type switch in
yeast) for use in mammalian cells. In this system, the
HO endonuclease is expressed by a recombinant adeno-
virus resulting in cleavage of its target site (on episomes)
with high efficiency (depending on the MOI), and repair
occurs via simple end-joining during a time course ofinfection. We previously utilized a mouse mammary cell
line containing a single integrated HO target site at a de-
fined genomic location [16]. Whereas, this has generated
powerful and useful information, for example in terms
of the effects of chromatin on generation of the DSB
and in repair [16,17], for other purposes the system is
limiting. For instance, damage induced by IR or geno-
toxins results in multiple simultaneous DSBs instead
of a single break, which immediately raises questions
in terms of similarity of activation and deactivation of
the DNA damage response (DDR). It is of significant
interest to the field of mammalian DSB repair to de-
velop a model system, where there is synchronous in-
duction of multiple ‘homogeneous’ site-specific DSBs
in a population, and then be able to stop the nuclease
activity rapidly [18].
Different assays, such as treatment of pre-cleaved plas-
mids with cellular extracts or transfection of linearized
DNA templates into mammalian cells have been employed
to study several different aspects of end-joining (efficiency
of joining of different DNA ends, fidelity of repair
[13,19-21]). However, technical limitations prevent a clear
picture from emerging regarding the end-joining effi-
ciency/fidelity and nature of sequence rearrangements.
For instance, Smith et al., using a transfection assay re-
ported a similar efficiency of end-joining for different
DNA ends. However, Poplawski et al., using cellular ex-
tracts have reported widely varying degree of efficiency of
end-joining with different end structures [13,22]. In fact, a
recent report presented evidence for strikingly different
repair efficiency using either lipid-based transfection vs.
nucleofection [23]. This highlights the importance of con-
ducting end-joining assays in a ‘nearly unperturbed’ cellu-
lar environment. Where looked at repair fidelity of a DSB
at an integrated chromosomal locus [24] most studies
were limited in terms of low cleavage efficiency, absence
of multiple defined site-specific DSB sites, and also the
persistent activity of the nuclease employed. We thus
wanted to investigate the repair fidelity in an episomal
population. It is well established that EBV-based episomes
become chromatinized and behave as minichromosomes
[15,25]. High density MNase maps for EBV-based epi-
somes have been generated that have revealed highly posi-
tioned nucleosomes and putative origins of replication
[26]. Hence, repair studies of minichromosomes can
also bring into focus the contribution of chromatin,
closely resembling genomic damage. Finally, we wanted
to characterize the effect of a recently identified im-
portant component of human NHEJ, known as Met-
nase, as an endonuclease on episomal repair fidelity in
intact cells. Metnase has been shown to be a general fa-
cilitator of NHEJ increasing both accurate and inaccur-
ate repair [27]. Mutation of its nuclease domain has
been shown to prevent this role, at least in a subset of
Rath et al. BMC Molecular Biology 2014, 15:6 Page 3 of 15
http://www.biomedcentral.com/1471-2199/15/6end-joining events [28,29]. Using in vitro assays, Met-
nase has been shown to have a preference for single
stranded DNA overhang of a partially duplex molecule
with an effect more pronounced on a 3′ overhang [29].
Evidence from experiments done with plasmid-host cell
transfection system, point to a significant role of Met-
nase in determining repaired junction fidelity for breaks
with 3′ overhangs. Also, in a transfection assay coupled
with integration, over-expression of Metnase did not sig-
nificantly increase accurate NHEJ at the break site [27].
Beck et al., reported a role of Metnase in promoting end-
joining with non-compatible ends (both 5′ & 3′) in a cell
free system [29]. However, a very recent study reported
against any functional role of Metnase in promoting end-
joining of modified DNA ends using a similar cell free sys-
tem [30]. These contradictory findings hint towards a gap
in knowledge regarding the role of Metnase as an endo-
nuclease processing different ends [31], and even greater
in intact cells. We wanted to determine the contribution
of Metnase in altering repair fidelity (accurate vs. inaccu-
rate repair) in our model system and to characterize the
nature of nucleotide rearrangements to understand more
in depth NHEJ fidelity in human cells.
Methods
Preparation of stable cell lines maintaining episomal
HO-CAT plasmid
The 34 bp HO endonuclease target sequence (agatcttt-
tagtttcagctttccgcaacagtata) was cloned in to the HindIII site
of the pREP4/CAT shuttle vector just before the chloram-
phenicol acetyl transferase (CAT) coding sequence and the
plasmid was renamed as HO-CAT plasmid. Further, HO-
CAT plasmid was transfected in to 293 T cells which main-
tain the plasmid episomal due to presence of EBNA-1,
under hygromycin selection (Hygromycin B/Calbiochem,
Cat # 400052). The cell line was named 293 T-HO-CAT.
Similarly HEK293 cells were transfected and selected to
produce the 3-HO-CAT cell line. Metnase expressing
pCAPP-Metnase-V5 plasmid which was prepared in Robert
Hromas’ lab was transfected in to 293 T cells and puro-
mycin (Puromycin Dihydrochloride/MP biomedicals, Cat #
100552) selected to produce the Metnase over expressing
293 T stable cell line. Subsequently, HO-CAT plasmid was
transfected into these cells to produce the Met-T-HO-CAT
cell line and maintained under dual selection of hygromy-
cin and puromycin. GenePORTER (Genlantis, Cat #
T201007) was used as the transfection reagent for all the
above mentioned transfections. All the three cell lines were
cultured using DMEM with 10% FCS as growth medium at
5% CO2 and 37°C.
Assay for DNA cleavage and repair
In a typical assay, for each different time point, 150,000
cells were infected with the recombinant adeno virusencoding HO endonuclease (Gift from Dr. Hamish Young,
Columbia University, NY, USA) at 10–30 MOI, referred to
as pPF446::HO in a plasmid map in [32]. DNA from cells
was collected using either Wizard SV genomic DNA purifi-
cation system (Promega, Cat # A2360) or Wizard plus SV
miniprep DNA purification (Promega,Cat # A1460) proto-
col. Equivalent amount of DNA was used in PCR and
qPCR reactions for CAT and AMP regions using GoTaq
DNA polymerase kit (Promega) and DynAmo Flash SYBR
Green qPCR kit (Thermo Scientific, Cat # F-415S) respect-
ively. 5′-CTACAACAAGGCAAGGCTTGACC-3′ and 5′-
TCTAGTTGTGGTTTGTCCAAACTCATC-3′ were used
as forward and reverse primers respectively for CATampli-
con. 5′-TTCCGTGTCGCCCTTATTCCC-3′ and 5′-GG
CACCTATCTCAGCGATCTG-3′ were used as forward
and reverse primers respectively for AMP region in PCR
reactions. PCR conditions: 30 cycles of 94°C for 30 s, 55°C
for 30 s, and 72°C for 39 s with a final extension of 10 mi-
nutes at 72°C. The CAT signal was normalized to AMP sig-
nal. For qPCR, 5′-GTACCAGCTGCTAGCAAGCT-3′
and 5′-TCAACGGTGGTATATCCAGTGAT-3′ were used
as forward and reverse primers respectively for the CAT
region (amplicon size 133 bp). 5′-CATCGAACTGGAT
CTCAACAGCG-3′ and 5′-GTCATGCCATCCGTAAGA
TGCT-3′ were used as forward and reverse primers
respectively for AMP region.
Immunoblotting
Protein samples from different time points were col-
lected by RIPA lysis buffer (50 mM Tris pH 8.0, 0.1%
SDS, 1% Triton-X, 1 mM EDTA, 150 mM NaCl, and
with 1X protease inhibitors – SIGMAFAST protease in-
hibitor cocktail tablets, Cat # S8820) and quantitated
using BCA protein assay kit (Pierce, Cat # 23223). Equal
amounts were run on a 12% polyacrylamide gel, blotted
on to Immobilon-P (Millipore, Cat # IPVH08100), and
subsequently probed with anti-E3-11.6 K antibody (fu-
sion protein with HO). The antibody was a kind gift
from Dr. William S.M. Wold, St. Louis school of medicine,
Missouri, USA. The blot was re-probed with Phospho-
(S/T)Q-ATM/ATR substrate antibody (Cell Signaling, Cat
# 2909S). Anti-Rabbit-HRP conjugated antibody (Cell sig-
naling, cat # 7074S) was used as the secondary antibody.
Stripping was done using Re-Blot plus mild (Millipore,
Cat # 2502). The blot was either developed using Pierce
ECL reagent (Thermo Scientific, Cat # 32106) or Opti-
4CN (Bio-Rad, Cat # 170–8235).
NheI or NotI screening and bacterial transformation
Plasmids recovered from each different time point were
subjected to NheI (or NotI) digestion (Promega, Cat #
R6501) which has its recognition sequence very close to
HO induced cleavage site. Subsequently, the enzyme
was heat inactivated and the miniprep DNA was used
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Cat # 200236) and plated on an Ampicillin plate
(100 μg/mL).
Replica plating assay
Plasmid DNA isolated from different cell lines at differ-
ent time points was used to transform was incubated for
16 h at 37°C and subsequently replica plated on a chlor-
amphenicol plate (50 μg/mL). Colonies were counted
with Bio-Rad ChemiDoc (Cat # 170–8265) machine
using Quantity-One software.
Luciferase assay
The HO-Luc plasmid was transfected using GenePOR-
TER (Genlantis, Cat # T201007) and concomitantly in-
fected with adeno-HO virus in either 293 T-HO-CAT
cells or 293 T cells. At each time point, cells were
taken of the plate and one aliquot of it was used to ex-
tract the DNA to be used for PCR to assay cleavage
and repair. The rest of the cells were assayed for lumi-
nescence using Luciferase Assay system (Promega, Cat
# E1501). GFP fluorescence was used to normalize the
luminescence values. Both luminescence and fluores-
cence were measured by Synergy 4 plate reader by
BioTEK instruments.
Southern Blotting for plasmid DNA
One fully confluent T75 flask was used for each time
point. Plasmids were recovered using Zyppy plasmid Kit
(Zymo Research, Cat # D4019). 10ug of plasmid DNA
from each time point was digested with either Csp45I
and NotI or Csp45I alone. Heat inactivated samples
were run in 1% agarose-gel. Blotting onto Immobilon-
Ny + (Millipore, Cat # INYC00010) was achieved using
Trans-Blot SD semi-dry transfer cell (Biorad, Cat #
170–3957). EKONO hybridization buffer (Research
Products International, Cat # 248800) was used for
both pre-hybridization and hybridization. Hybridization
probe was synthesized by random priming using ran-
dom hexamers (Invitrogen, Cat # 51709) using whole
plasmid DNA as template. Finally, the blot was exposed
to X-ray films and developed using standard developer.
Preparation of cell extracts
About 1 million cells were used to prepare the whole
cell extract for each mentioned time point. Cells were
collected off the plate and washed once with cold 1X
PBS. Subsequently, the cells are washed once with hypo-
tonic buffer (25 mM Tris pH 7.9, 1 mM MgCl2, 0.4 mM
CaCl2, and 0.5 mM DTT), spun down, and resuspended
again in 200 μL of hypotonic buffer and kept in ice for
20 minutes. The cells were homogenized in a tight fit-
ting Dounce homogenizer (30 strokes) and the debris
was spun down by spinning at 13000 rpm for 10 minutesat 4°C. The supernatant is collected and used in the
DNA cleavage reaction.
In vitro DNA cleavage assay
The reaction was carried out in a 10 μL reaction mix-
ture with 250 ng of pMat-Puro plasmid, 6 mM MgCl2,
50 mM NaCl, 5 units of XmnI enzyme (Promega, Cat#
R727A) (0.5 μL), and 2 μL cell extract for each given
time. The mixture was incubated at 30°C for 1 h.
Then, the reactions were stopped by adding 5 μL of
stop solution (100 mM EDTA, 1% SDS, 1 mg/mL Pro-
teinase K) and 3 μL of 6× loading dye and incubated
at 55°C for 30 min-1 h. Then, the mixture was run in
a 1% agarose gel.
Results
Development of an episomal model system to study DSB
repair
We initially established a cell line (human 293 T) trans-
fected with a shuttle vector with the HO target site
cloned into it (293 T-HO-CAT) (see methods for de-
tailed description). The vector is maintained as a stable
copy number episomal unit inside the mammalian cells
because of the presence of EBNA-1 protein encoded by
the vector (Figure 1A) [33]. This provides us with mul-
tiple copies of homogenous template which become
chromatinized and have been shown to accurately reflect
repair of genomic DNA [14]. Minichromosomes are
physiologically relevant but simple substrates to study
DNA repair. Being homogenous in nature and also the
ability to isolate them from bulk chromatin are some
other advantages of the episomal system. We are conduct-
ing studies by sucrose gradient sedimentation of isolated
episomes that have revealed highly ordered, chromatinized
plasmid species (to be published elsewhere).
In a typical cleavage and repair assay, a single site spe-
cific DSB was generated in the episomal population by
infecting the cells with recombinant adeno-virus (Ad-
HO) encoded HO endonuclease [16,32] that recognizes
a 34 base pair (bp) specific sequence and produces a
DSB with a 4 bp 3′ overhang. Repair was followed in a
time course after isolating the population of plasmids
and using endpoint PCR and q-PCR detecting an ampli-
con spanning the break site (Figure 1B, CAT amplicon,
Figure 1C). Upon induction of the DSB, the PCR pro-
duct is lost, but then recovers with time as the repair
proceeds. The Ampicillin region on the vector was used
as an internal normalization control for plasmid reco-
very. The cleavage efficiency of HO-site was consistently
>90% as judged from multiple experiments at 10–30
MOI. We have previously shown robust DDR activation
due to HO induced site-specific cleavage across the
episomal population that matches the kinetics of repair
in terms of appearance and disappearance of S1981
Figure 1 Typical episomal cleavage and repair assay. (A) Map of the pRep4-HO-CAT plasmid showing key features. HO recognition cassette is
cloned in just before CAT gene. Arrows indicate location of the primers. (B) Episomal cleavage-and-repair assay at the HO site DSB during a time
course of Ad-HO infection. T-HO-CAT cells were infected with adeno-HO (Ad-HO) virus, cells were collected at different time points, and episomes
were recovered. PCR was performed by putting primers across the break site (CAT amplicon). AMP (Ampicillin) region on the episome acts as the
positive internal control and used for normalization. In addition, a genomic product was also used to ensure equal total DNA recovery from the
samples. (C) qPCR analysis for kinetics of cleavage and repair of epsiomes as explained in (B). qPCR values are represented as (CAT/AMP)% over
control. (D) Same as in (C) but in presence of the ATM inhibitior-KU55933 (10 μM).
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with permission in Additional file 1: Figure S1). Such
data confirm previous observations of DDR activation
with as little as 10–20 DSBs or even with a single DSB
[35-37]. To ensure that the episomal repair derives a sig-
nificant contribution from the DDR, we treated the cells
with the ATM inhibitor KU55933. The kinetics of repair
in the drug treated cells was slower in comparison to
untreated control (Figure 1D). These results show that
in this system an active DDR pathway is elicited due to
presence of multiple DSBs. Of interest, some previous
studies have suggested the non-essential role of ATM
during much of NHEJ events, based largely on evidence
from mutant cell lines, except for instances of condensed
heterochromatic sites [38]. In this episomal system,
while we have abundant direct evidence that the plas-
mids are chromatinized and supercoiled, presence of
heterochromatic regions are not believed to be likely.
Since, for example, histone H1 is found only in smallamounts in association with episomes (and their nucleo-
somes) after isolation on sucrose gradients [[25] and
data not shown].
Kinetics of HO expression and inactivation
In Figure 2 we show a typical experiment with the kinet-
ics of HO expression. In initial studies, we have observed
a second cleavage cycle between 24-36 h Post-infection
(PI) that could be explained by release of new virus and
reactivation of the promoter driving HO expression in
293 T cells. For a study of repair fidelity, it is important
to have the cleaving endonuclease transiently active.
This reduces the bias toward inaccurate repair of the
joint introduced in the system by the recurrent cutting
and accurate restoration of the recognition sequence. In
this context, Kaplun et al., have shown that HO is a tar-
get of Mec1/ATR mediated phosphorylation leading to
its subsequent ubiquitination and degradation in yeast
[39]; an obvious mechanism for haploid yeast to avoid
Figure 2 Expression and activity of HO-fusion protein in permissive cell system (293 T cells). (A) Depicts immunoblot of HO fusion protein
upon infection with adeno-HO virus at different time points in 293 T-HO-CAT cells. A map of the virus showing the HO fusion is presented in
[32], and generates a presumed chimeric protein with the 11.6 k adenovirus gene product. Cells were lysed using RIPA lysis buffer and equal
amounts of proteins were loaded and run in a 10% SDS-PAGE gel and subsequently probed with anti-E3-11.6 K (fusion protein with HO) antibody.
The blot in panel (A) was re-probed with phospho-(S/T) Q-ATM/ATR substrate antibody, and the region of the blot corresponding to the position
of HO in panel (A) is shown. Also shown, the p(S/T)-Q banding pattern in 293 T cells which lack the episomes after Ad-HO infection, to serve as
a control. ? denotes undetermined bands obtained after probing with p(S/T)-Q antibody. (B) HO activity was measured in an in vitro cleavage reaction.
Cell extracts were prepared from 293 T cells (lanes 1–5) and cells carrying pRep4-HO-CAT episomes (T-HO-CAT cells) (lanes 6–7) after Ad-HO infection
at given time points. The plasmid pMat-Puro, harboring the HO recognition site [16], was added exogenously at 250 ng per reaction. The plasmid was
treated with cell extracts obtained from different time points from both 293 T cells and T-HO-CAT cells. HO activity was judged by presence/absence of
a cleaved product. In reactions shown in lanes 1–7, we have added Xmn1 to produce the ~750 bp band and corroborate the cleavage at the HO site.
Lane 8 shows the treatment of the pMat-Puro plasmid with extracts obtained from uninfected cells (Unc). “M” denotes the Promega 1 Kb DNA ladder
as a molecular weight marker.
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We have previously shown that in a non-permissive cell
system, HO expression shuts down by 3 h of infection,
ensuring (mostly) a single round of cleavage/repair impli-
cating the existence of a similar mechanism in mouse
cells [40]. In these cells (MM3MG mouse cells - non-
permissive to human adeno virus) the HO protein, is
expressed soon after infection leading to cleavage of
its target site. But subsequently, ATM activation, andphosphorylation of HO results in its proteolytic loss with
no new net synthesis [16], thus explaining absence of re-
current cutting of the restored target site and the enzyme
is then degraded.
However, in a replication permissive system (human
293 T cells) HO nuclease persists throughout the infection
(Figure 2A) due to a complex pattern of activation of early
and late promoters usage [41] driving the E3/11.6-HO fu-
sion [42]. We should caution that the identification of this
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mains uncertain. Unfortunately a published HO antiserum
is not available, and the way to detect the HO was through
its fusion with the 11.6 k protein [32,42], but previously
presence of this product had been correlated with the nu-
clease activity [16]. Assuming we have correctly identified
the HO protein, however, it was unclear whether the HO
enzyme remained active after cutting its target(s) or if it
became nonetheless inactivated via its ATM/ATR-medi-
ated phosphorylation. Maintenance of HO activity would
elicit multiple rounds of cleavage and repair of the epi-
somal targets, and the fundamental question was whether
the pattern of repair (recovery of the CAT PCR product)
was the result of a single round of cutting and repair, or a
more complex pattern of cycles of cleavage and re-
ligation. To answer this, first we determined that HO in-
deed became phosphorylated (by ATM/ATR) in this sys-
tem, after we re-probed the HO-WB with a phospho-Ser/
Thr (S/T) ATM/ATR substrate antibody (S/T-Q motif
is the well characterized target of ATM/ATR substrates
[43] and is also present in HO). Figure 2A shows rapid
S/T-Q phosphorylation of the band co-migrating with
HO that paralleled the cleavage of plasmid and the kin-
etics of ATM activation in this system [34] (Additional
file 1: Figure S1). Treatment with λ phosphatase abolished
the signal (not shown). In contrast, infection of plain
293 T cells showed a number of phospho-S/T-Q immune-
reactive bands, but none that corresponded to the HO
position or that corresponded to phospho-proteins in-
duced after doxorubicin treatment (Additional file 2:
Figure S2). In short, a possible scenario is that HO be-
comes S/T-Q phosphorylated after (maximal) cleavage
of the bulk of episomes; and no longer seems to cleave
until viral replication is complete and the next cycle of
infection begins (the cells do not lyse until ~5-7 days later).
To confirm that HO is indeed inhibited following a
single round of cleavage and repair, we performed two
types of experiments, one with extract of HO-infected
cells supplemented with a reporter plasmid exogenously
and one in intact cells. We already knew by WBs that
the HO fusion protein varies little throughout the time
course of infection, but its activity seems to be limited to
the first hour, after which the enzyme is phosphorylated
by ATM/ATR and appears to be inhibited. We postu-
lated that the source of ATM/ATR activation is the HO
induced cleavage of HO-CAT episomes as shown previ-
ously (Figure 2 in [34]; Additional file 1: Figure S1).
Hence, preparing the cell extract from Ad-HO infected
293 T cells not carrying the episomes would effectively
avoid ATM/ATR activation, thus maintaining an active
HO endonuclease. We thus prepared cell extract from
both 293 T cells and cells carrying the episomes (T-HO-
CAT cells) at different time points post infection with
Ad-HO virus. As shown in Figure 2B, addition of pMat-puro plasmid (carrying a HO recognition site, [16]) to
uninfected cell extract (lane 8) results in no appreciable
cleavage (after 1 h of incubation in vitro). However, in-
cubation in Ad-HO infected 293 T cell extracts collected
at different time points results in complete linearization
of the plasmid even after the first hour PI, and the HO
activity remains so for the next 6 h, as judged by the ap-
pearance of cleaved product (we also added Xmn1 to
these reactions to enhance the distinction between the
linearized plasmid and the mobility of the relaxed circu-
lar form). In contrast, in cells carrying the pRep4-HO-
CAT plasmid (labeled T-HO-CAT), the enzyme is active
only for the first hour PI, but not after 4 h (note pres-
ence/absence of the cleaved product) (Figure 2B), indi-
cating that the HO is inactive following cleavage of the
endogenous episomes. Treatment of this ‘HO extract’
with λ phosphatase gave some return of cleavage but
with unclear results as there was more plasmid smear
(not shown).
For the experiment in vivo, we transfected a Lucifer-
ase/GFP reporter [44] in Ad-HO-infected the 293 T-
HO-CAT cells. In the Luciferase reporter, the HO target
site separates the promoter from the ORF. The Lucifer-
ase expressed is short-lived, so that only sustained syn-
thesis results in sufficient expression. New synthesis of
Luciferase, measured as enzyme activity lags about an
hour after DSB repair, when compared with PCR, which
also showed a single prominent repaired band of correct
size with no evidence of deleted products [44]. Lucifer-
ase was measured at 2 h intervals for 12 h, and the Ad-
HO infected samples were compared to the uninfected
samples for the same time points (Figure 3). In addition,
DNA from each time point was recovered to determine
the kinetics of cleavage and repair of the HO-CAT epi-
somes. Figure 3, lower panel (CAT amplicon) shows that
most of the target site is cleaved by 2 h with the repair
product back to control level by 6-8 h post infection.
The reporter plasmid also showed a similar pattern of
Luc activity, an indication of cleavage/repair and then
expression kinetics. If the HO was still active after 4 h of
infection, then this would result in concomitant cutting
of the Luc reporter, and be reflected as an initial delay in
Luciferase expression (as evident in difference of slopes
between uninfected and infected samples between 0-6 h)
or slower accumulation kinetics (RLUs produced) in
comparison to the uninfected control. Figure 3 shows
that the pattern of Luciferase activity in the infected
samples closely parallels the pattern as in the uninfected
samples. Taken together, these results strongly suggest
that even in a permissive system, HO gets inactivated
by 4 h time point after infection, limiting its cleavage
activity to just once in an experimental window of
0-12 h, or at least all the period in which ATM remains
active. Of course, the situation changes once the viral
Figure 3 Luciferase expression in 293 T-HO-CAT cells at different time points. The cells were transfected with the vector construct with HO
target site cloned in just before the Luciferase ORF (shown on top). Luciferase expression was measured in both uninfected and Ad-HO infected
cells and normalized to GFP expression. Both infection and plasmid reporter transfection were carried out concomitantly. PCR shows the cleavage
and repair kinetics across the time points in the HO-CAT episomes.
Rath et al. BMC Molecular Biology 2014, 15:6 Page 8 of 15
http://www.biomedcentral.com/1471-2199/15/6replication is complete and one must take into account
multiple rounds of infection in the event of absence of
cell lysis. Despite the appeal of this mechanism of ATM
involvement in HO inactivation, we acknowledge that
our results remain correlative. A definitive proof could
be obtained with the generation of a new system in AT-
cells, but then again the possibility exists that it is in-
stead ATR that is involved in phosphorylation andinactivation of HO. However, it remains clear that only
one round of cutting is obtained in the first few hours
of Ad-HO infection.
High Fidelity repair of episomes via NHEJ
We wanted to study the repair fidelity of end-joining in
this episomal system. The HO site is positioned just
before the chloramphenicol resistance marker (CAT)
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any alteration in the form of deletions or insertions
would profoundly affect expression of CAT and result in
chloramphenicol sensitivity, detected by replica plating
the LB-Ampicillin bacterial plate onto chloramphenicol
Plates. 293 T-HO-CAT cells were infected with adeno-
HO virus to induce the site-specific DSB. Plasmids were
rescued from cells at each time point and were back
transformed into supercompetent bacteria and plated
on LB-Ampicillin. Somewhat to our surprise, almost
all of the bacterial colonies could replica-plate on chlo-
ramphenicol and virtually all the rescued plasmids were
‘unmutated’. Boil preps were analyzed from over 200
randomly chosen clones across different time points. As
shown in Figure 4A, almost all of them revealed presenceFigure 4 High fidelity repair in T-HO-CAT cells. (A) Episomes were reco
subsequently used to transform bacteria, and plated on ampicillin plates. B
to obtain the episomes and were run on 0.8% agarose gel to depict differe
obtained from random clones of 4, 6, and 8 h plates PI was performed to r
and description in text). (C) PCR was performed across the DSB site using prim
clones picked up from 4 h and 6 h time point plates and subsequently run in
repaired clones were removed after isolating the episomes from cells at g
inaccurately repaired plasmids (truncated ones). Episomes recovered from
and subsequently transformed. Plasmids were subsequently obtained fro
0.8% agarose gel. ‘U’ denotes uncut control plasmid. ‘C’ denotes SalI cleaof right sized plasmids (10.9 Kb). Smith et al., have previ-
ously reported an average deletion size of 250 bp for a 3’
complementary overhang in a plasmid host-cell transfec-
tion assay [13]. To easily identify clones within a deletion
range of 250–500 bp, we employed SalI digestion to
screen random clones picked from two different time
points. SalI restriction sites are present on both sides of
the break site (refer plasmid map in Figure 1A) and upon
digestion should give a 9 Kb fragment and a 1.9Kb frag-
ment. We could not detect any obvious deletions among
these random clones, none affecting SalI site(s), and all of
them yielded correct sized fragments (Figure 4B). We also
performed a PCR screen across the break using closely
spaced primers (120 bp amplicon) in order to detect
micro-deletions or insertions. Plasmids obtained fromvered from cells after Ad-HO infection at 4 h and 6 h time point,
oil prep of random clones from the 4 h and 6 h plates was performed
nce in size after repair (10.9 Kb in size). (B) SalI digestion of plasmids
eveal deletion in the range of 250–500 bp in size (Refer plasmid map
ers generating amplicon size of 120 bp with plasmids from random
a 2.5% agarose gel to reveal micro deletions or insertions. (D) Accurately
iven time points PI by employing NheI digestion, thus enriching for
cells at indicated time points were digested with NheI overnight
m random clones across different time points and were run on a
ved control plasmid.
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PCR using these primers. However, we were unable to de-
tect any such clones with small deletions (Figure 4C) (we
previously noted that resection of a 4 bp 5′-overhang with
S1 nuclease or its fill-in with Klenow was visibly shifted
on a 2.5% agarose gel). In fact, most instances of rear-
ranged clones could only be identified after digesting the
rescued plasmids with NheI which has its recognition se-
quence on both sides and very close to the HO site. Ac-
curately repaired plasmids would maintain the NheI site
and get linearized upon digestion and thus hardly trans-
form bacteria [The background of colonies from NheI-cut
plasmids not processed for repair in mammalian cells was
~4 logs less than uncut plasmids; while for plasmids with
3′ overhangs (as produced by digesting with PstI or HO)
was even less]. Forced selection of plasmids (deleted in
mammalian cells) in this fashion; revealed presence of ex-
tensively truncated plasmids from different time points,
upon transformation into bacteria (Figure 4D).
To summarize, deletions/insertions in the recovered
plasmid population from T-HO-CAT cells at different
time points during the course of repair was a very rare
event and could only be detected in less than 10% of res-
cued plasmids.
As a means to quantitatively and independently esti-
mate accurate/inaccurate repair, and also to be sure that
cutting and repair was indeed taking place, we also
employed the Luc reporter as in Figure 3. Since the HO
site is cloned immediate upstream of the Luciferase
ORF, any alteration at the repair site would result in loss
of Luciferase normalized to GFP fluorescence at the
undamaged site. In a transient transfection assay,
293 T cells were transfected with the reporter plasmid
with or without concomitant infection with Ad-HO
virus. Luciferase and GFP expression in these assays be-
comes clearly detectable by 4 h even with a trans-
fection efficiency of 20-30% (Figure 5B). Maximal
Luciferase accumulation (~106 photons/sec - set as 1)
is achieved after ~16 h (Figure 5A). An initial reduc-
tion in Luciferase light units is indicative of DSB in-
duction due to turn over of the enzyme about 3 h
later, but subsequently accurate repair reveals full re-
covery of luminescence (Figure 5A). These results in-
dicated that at least in this system, NHEJ mediated
end-joining is generally highly accurate.
Metnase promotes end-processing and erroneous repair
In context of DNA repair proteins, a major difference
between 293 T cells and HEK 293 cells is that Metnase
is not expressed in 293 T cells but is expressed in HEK-
293 cells [45]. To determine the effect of Metnase
expression on episomal repair fidelity, we conducted
an identical study using HEK 293 cells. Stable cell line
(3-HO-CAT) was generated maintaining multiple copiesof pREP4/HO-CAT plasmid. We also over-expressed
Metnase in the 293 T-HO-CAT cell line that lacks en-
dogenous Metnase (Figure 6A). DSB repair assays in all
the 3 cell lines were carried out in parallel and replica
plating was carried out to fish out clones with altered re-
pair junction. As shown in Figure 6C and 6D, HEK 293
cells (express Metnase) revealed a population of plas-
mids (30-35%) harboring deletions. Similarly, over ex-
pression of Metnase in Met-T-HO-CAT cell line
(293 T cells lack Metnase) resulted in high frequencies
of deletions in 40-45% of total plasmid population (we
analyzed typically at least 10 plates). In addition, there
were fewer overall colonies obtained, suggesting more
degradation in Metnase expressing cells. These results
suggest a prominent role for Metnase in endonuclease
processing at least in case of DSBs that leave a 4 bp
3′ overhang. Further, using qPCR we also found that the
yield of plasmids with repaired joint, generating the
CAT PCR product, was lower in cells overexpressing
Metnase across different time points PI (Figure 6B).
Further, to assess the frequency and nature of re-
arrangements, we removed the accurately repaired
clones from the rescued plasmid population (at 4 h PI)
by NotI digestion (refer to plasmid map in Figure 7C)
from both 293 T-HO-CAT cells and Met-T-HO-CAT
cells. A large increase in number of colonies that did not
replica-plate was obtained with episomes rescued from
Met-T-HO-CAT cell line in comparison to T-HO-CAT
cells, independently confirming results obtained in Fig-
ure 6C. As shown in Figure 7A (upper panel), presence
of Metnase generated a population of plasmids widely
varying in their deletions. A significantly smaller number
of clones were recovered from T-HO-CAT cells for the
corresponding time point (Figure 7A, lower panel and
Figure 4D) and almost all of them are extensively de-
leted. Figure 7B shows distribution of random clones
obtained from these two different cell lines with diffe-
rent extent of deletions.
Study of early repair events and nucleolytic processing
of the episomes after HO induced cleavage by
Southern blotting
To probe the cleavage and repair of episomes at a mo-
lecular level, we resorted to southern blotting at differ-
ent time points post-Ad-HO infection. Such a method is
expected to emphasize the most prominent cleavage
products obtained in the HO-infected population, to
generate prototypical episomal processing patterns. The
control plasmid (pREP4-HO-CAT from non-infected
cells) was digested with Csp45I and NotI to yield bands
of size close to 9Kb and 2Kb (N.I. 1st lane, Figure 7D).
Plasmids rescued at different time points from infected
cells were digested with Csp45I only (refer plasmid map
in Figure 7C). As the NotI site is adjacent the HO site,
Figure 5 Assay for repair fidelity in T-HO-CAT cells using luciferase reporter. (A) Luciferase activity in 293 T cells upon transfection of
HO-Luc reporter as in Figure 3 at different time points. (B) Demonstration of GFP-positive cells at 4 h post transfection as a measure of
transfection efficiency.
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http://www.biomedcentral.com/1471-2199/15/6we should expect to observe a similar banding pattern as
for the control (1st lane) upon action by HO endonucle-
ase. Figure 7D shows an expected cleavage pattern.
Interestingly, we also observed a band migrating faster
than the 9 Kb product (see 4 h time point, arrowhead)
and a smaller species of approximately 1.5 kb that could
represent further nucleolytic processing of DNA frag-
ments following the initial HO cleavage.
In the presence of elevated Metnase expression (Met-
T-HO-CAT cells), quantitatively the recovery of intact
episomes after the given time window for repair (indi-
cated as 11Kb band product) was less in comparison toepisomes recovered from cells without Metnase (com-
pare the 4 h and 6 h PI lanes; Figure 7D). Of note, we
would like to remind that similar results were obtained
with quantitative PCR showing that overexpression of
Metnase delayed the kinetics of repair, resulting in di-
minished yield of repaired episomes for a given time
point in comparison to control (Figure 6B), indepen-
dently confirming the southern blot finding.
Sequencing of deleted clones obtained from Metnase
over expressing cells revealed a recurrent pattern of DNA
resection observed at the break site. Many clones lack a
region of sequence, close to 200 bp in length, upstream of
Figure 6 Metnase promotes erroneous end-processing. (A) Immunoblot showing stable Metnase overexpression in Met -THO-CAT cells along
with endogenous level of Metnase in 3-HO-CAT cells. Arrow marks the correct size band for Metnase in the indicated cells. (B) qPCR analysis of
kinetics of episomal cleavage and repair in 293 T cells (without Metnase) and Met-T-HO-CAT cells (expressing Metnase) as described in Figure 1B
& 1C. qPCR values are represented as (CAT/AMP)% over control. (C) Replica plating assay conducted for indicated time points in three different
cell lines with varying Metnase expression. (D) Table showing average replica plating efficiency obtained from 3 different time points for each cell
line and from three independent experiments.
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neously resected (5′ to 3′ direction) on the other side of
the DSB (Additional file 3: Supplementary text files 1 &
2). This is consistent with a very similar observation previ-
ously reported in yeast for HO induced breaks [46]. There
is remarkable similarity in terms of position and segment
length of the missing region found on different clones,
which are of different sizes. In this regard, it is worth men-
tioning a very recent report by Adkins et al., involving
studies done with nucleosomal substrates, presented evi-
dence for requirement of a nucleosome-free gap region
adjacent to the DSB for Sgs1-Dna2 dependent resection
machinery [47]. Very recently, resection proteins Sgs1 and
Exo1 have been also implicated in G1 checkpoint activa-
tion in budding yeast [48]. Of note, a nucleosome plus
the linker region is approximately 200 bp of DNA se-
quence. We also had made similar observations for precise
removal of nucleosomal-length fragments at the singlegenomic HO-DSB in the MM3MG model when in
the context of heterochromatin [17]. This suggests the in-
volvement of a common mechanism for providing a tem-
plate more amenable for endonucleolytic processing,
especially active in presence of Metnase. As a last observa-
tion we should note that the Southern blots also indicate
that the repair mechanism appears to be predominantly
accurate NHEJ (simple plasmid re-ligation) for these epi-
somes, as we have rarely observed evidence of formation
of concatemers, even when the population of plasmids
was not completely cut, and thus offering intact template
strands for HR between plasmid molecules, thus presum-
ably resulting in Holliday junctions and concatemeric
units that we were unable to detect on Southern blots.
Even after presumably inhibiting NHEJ with a general in-
hibitor of PIKs (Wortmannin) or a more specific inhibitor
of DNA-PKcs (KU55933) and hence shifting the balance
more in favor of HRR, the majority of repair was again
Figure 7 Characterization of effect of Metnase on end-processing. (A) Representation of deleted clones obtained from Met-T-HO-CAT cells
and T-HO-CAT cells after NotI digestion of rescued plasmid population at 6 h time point post-infection. (B) Size distribution of deleted clones
obtained from the two different cell lines. (C) Cartoon displaying position of different restriction enzymes on HO-CAT episome used for various
digestions and southern blot. (D) Southern blot for pRep4-HO-CAT fragments recovered at given time points PI from cell lines in presence or
absence of Metnase, after appropriate restriction digestion (see the description in text). N.I. denotes the episomes recovered from non-infected
cells. Different arrow positions show processed episomal products. 11Kb size arrow denotes the singly-cut plasmid. M denotes the molecular
weight marker, that is NEB 1 kb ladder labeled with PNK and γATP32.
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ition of the gel) was hardly increased (Additional file 4:
Figure S3). The Southern blot showed that NHEJ was
inhibited by the KU55933 (reduction of the 11 kb re-
ligated product) but there was only a modest shift toward
formation of concatemers (generated via HRR).
Discussion
In this report, we present results from an episomal
model system to study end-joining process in intact
mammalian cells upon induction of a DSB. This system
is designed to overcome the limitations of existing DSB
repair assays and gives the opportunity to evaluate end-
joining fidelity of multiple DSBs in a single cell with
4 bp 3′ overhang in vivo. We also evaluated the role ofMetnase and its contribution towards determining repair
fidelity in this system. We found that > 90% of the reco-
vered clones from the T-HO-CAT cells, which lack en-
dogenous Metnase, are precisely rejoined indicating high
fidelity of repair (Figure 4). This is in agreement with
some previous reports indicating highly accurate NHEJ
in mammalian cells [49-51]. In fact, a very recent report
suggested the repair accuracy to be as high as 99% in a
modified I-SceI mediated cleavage and repair assay and
also showed precise ligation to be mediated by classical
NHEJ components [52]. However, Metnase expression
may play a unique role in determining the fidelity of re-
pair specifically in humans. Metnase is only known to be
expressed in anthropoid primates (humans and apes). It
has both histone methylase and DNA endonuclease
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erroneous repair of DSBs (for a review [53]). Previous
reports using cell extract based assays have been incon-
clusive in determining the exact role of Metnase in pro-
cessing of DSBs with overhangs [29,30]. Upon Metnase
overexpression, we observed a 25-30% of inaccurately
repaired plasmids by replica plating assay. Molecular
analysis of recovered clones and direct southern blot re-
sults independently confirm this observation. This is
suggestive of a prominent role of Metnase as an endo-
nuclease for processing of DSBs. The southern blots spe-
cifically indicate a loss of full-length repaired products
(compare 6 h time point of T-HO-CAT and Met-T-HO-
CAT cells in Figure 7D). This is in accordance to a re-
cent report using cellular extract where addition of Met-
nase did not increase yield of repaired products but
resulted in increased resection and seemed to inhibit re-
pair [30]. However, by Southern blotting we also did not
find evidence of a role for Metnase in preventing larger
deletions (Figure 7B) as previously reported [27]. These
findings, along with evidence of clones with precise re-
moval of a nucleosomal-length fragment at the left (5′
side) of the break may implicate a broader role of Met-
nase in determining the outcome of end-joining events
in mammalian cells.Conclusion
We have carried out a careful analysis of the fidelity of
repair via NHEJ in mammalian cells using a high copy
number episomal system that can be cleaved to generate
homogeneous DSBs, and found that rather than error-
prone, the repair was highly accurate in most cases.
NHEJ was the predominant pathway of repair in this
system, where the majority of plasmid was cleaved and
leaving minimum number of intact copies for HR. The
outcome of the accurate repair depended on presence of
Metnase, a nuclease present in human cells, and which
generated a pattern of discrete deletions near the DSB
and resulting in much less accurate repair.Additional files
Additional file 1: Figure S1. DNA damage response (DDR) activation in
293 T-HO-CAT cells upon Ad-HO infection. Infection with Ad-HO virus
and generation of a single DSB in episomes (in T-HO-CAT cells) results in
the phosphorylation of ATM at S1981 (activation), TLK1 (S695, inhibition),
and H2AX (S139). Infection of 293 T cells that do not contain the HO-
targeted episomes does not result in sufficient ATM activation (bottom
panel). Cells were infected and whole cell lysates were collected at
indicated time points and immunoblotted with appropriate antibody.
“C” denotes the uninfected control. Drug combination (HU + TFP) was
used as a positive control for ATM activation due to DNA damage
(Reproduced with permission from [34]).
Additional file 2: Figure S2. pS/T-Q status in 293 T cells upon
doxorubicin treatment. WB for pS/T-Q proteins of 293Tcells incubated ornot with doxorubicin and then allowed to recover after removing the
drug for different hours (R1, R3, R5).
Additional file 3: Supplementary text files 1 and 2. Sequencing data
and alignment from selected deleted clones.
Additional file 4: Figure S3. Evidence for presence of rare concatemers
after DN-PKcs inhbition. 293 T-HO-CAT cells were treated 2 h prior to
Ad-HO infection either with Wortmannin (20 μM) or KU55933 (10 μM)
(potent ATM inhibitor). Episomes recovered from cells at indicated time
points and were processed as described previously in text and Figure 7.
Concatamers can be observed as slow migrating high molecular weight
forms (> 11Kb).
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